Clinical trial
Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy
NCT02478242 is registered in ClinicalTrials.gov with Kyungpook National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy
- Lead sponsor
- Kyungpook National University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- June 30, 2015
- Enrollment
- 60 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.